Company intelligence / Profile preview

Sidra Medicine

Ownership: Private
Employees: ~4000
Development stage: Commercial

Overview

Sidra Medicine is an advanced academic medical center providing world-class tertiary healthcare for women and children. It has pioneered several first-in-country procedures such as pediatric hematopoietic stem cell transplantation and advanced neurosurgical therapies. The institution is also engaged in biomedical research with an emphasis on personalized medicine

Therapeutic areas: OtherRare DiseasesWomen's Health
Modalities: BiologicCell therapyDeviceSmall molecule
Industry: Academic Hospital/University/Research

Partnerships

Weill Cornell Medicine-Qatar (WCM-Q)Qatar University (QU)Hamad Medical Corporation (HMC)Primary Health Care Corporation (PHCC)Qatar Biobank

Beyond the preview

Go deeper on Sidra Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sidra Medicine.

Explore the full profile